Clinical Trial Update: Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating bortezomib in patients with advanced or metastatic transitional cell cancer of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Cancer of the Renal Pelvis and Ureter

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED